| Literature DB >> 15829189 |
Dao M Nguyen1, Laurene Mascola, Elizabeth Brancoft.
Abstract
An outbreak of community-associated methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infection (SSTI) occurred in a college football team from August to September 2003. Eleven case-players were identified, and boils were the most common sign. Linemen had the highest attack rate (18%). Among 99 (93% of team) players with cultured specimens, 8 (8%) had positive MRSA nasal cultures. All available case-players' MRSA isolates characterized had the community-associated pulsed-field type USA300. A case-control study found that sharing bars of soap and having preexisting cuts or abrasions were associated with infection. A carrier-control study found that having a locker near a teammate with an SSTI, sharing towels, and living on campus were associated with nasal carriage. Successful outbreak control measures included daily hexachlorophene showers and hygiene education.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15829189 PMCID: PMC3320349 DOI: 10.3201/eid1104.041094
Source DB: PubMed Journal: Emerg Infect Dis ISSN: 1080-6040 Impact factor: 6.883
Figure 1Epidemic curve of clinical and methicillin-resistant Staphylococcus aureus skin and soft tissue infections among players on a college football team by date of diagnosis, Los Angeles County, August–September 2003.
Characteristics of case-players (N = 11)*
| Case-player | Age (y) | Field position | No. y on team | Date of diagnosis | Presenting sign | Site of infection | MRSA+ culture | MRSA genotype† |
|---|---|---|---|---|---|---|---|---|
| 1 | 20 | Fullback‡ | 2 | 8/15/03 | Boil§ | Knee | Y | A |
| 2 | 21 | Cornerback‡ | 2 | 8/17/03 | Boil§ | Elbow | Y | A |
| 3 | 20 | Linebacker | 2 | 8/19/03 | Boil§ | Elbow | Y | NA |
| 4 | 18 | Lineman | 1 | 8/20/03 | Folliculitis | Leg | Y | NA |
| 5 | 18 | Lineman¶ | 1 | 8/20/03 | Folliculitis | Knee | NC | – |
| 6 | 21 | Lineman‡ | 3 | 8/22/03 | Insect bite§ | Foot | Y | A |
| 7 | 18 | Lineman‡ | 1 | 8/25/03 | Boil§ | Elbow | Y | A |
| 8 | 20 | Lineman | 3 | 8/26/03 | Boil§ | Elbow | NC | – |
| 9 | 19 | Lineman | 1 | 8/27/03 | Boil§ | Forearm | NC | – |
| 10 | 20 | Tight end | 2 | 8/27/03 | Insect bite§ | Forearm | NC | – |
| 11 | 20 | Cornerback | 2 | 9/1/03 | Boil§ | Elbow | Y | NA |
*MRSA, methicillin-resistant Staphylococcus aureus; Y, yes; NA, not available for PFGE analysis; NC, not cultured (clinical diagnosis). †Genotype A is the community-associated MRSA strain (USA300). ‡Hospitalized. §Required incision and drainage. ¶MRSA nasal carrier.
Figure 2Football field positions; see Table 2 for position-specific attack rates. S, safety; LB, linebacker; CB, cornerback; L, lineman; WR, wide receiver; TE, tight end; QB, quarterback; TB, tailback, FB, fullback.
Position-specific attack rates of clinical and methicillin-resistant Staphylococcus aureus skin and soft tissue infections among players on a college football team
| Position ( | No. case-players (%), N = 11 | No. controls (%), N = 32 | Total no. on team (%), N = 107 | Position-specific attack rate (%)* |
|---|---|---|---|---|
| Lineman (L) | 6 (55) | 11 (34) | 33 (31) | 18 |
| Tight end (TE) | 1 (9) | 3 (9) | 6 (6) | 17 |
| Cornerback (CB), Safety (S) | 2 (18) | 4 (13) | 21 (19) | 10 |
| Linebacker (LB) | 1 (9) | 4 (13) | 12 (11) | 8 |
| Fullback (FB)/Tailback (TB) | 1 (9) | 3 (9) | 12 (11) | 8 |
| Wide receiver (WR) | 0 | 4 (13) | 12 (11) | – |
| Quarterback (QB) | 0 | 2 (6) | 6 (6) | – |
| Special team | 0 | 1 (3) | 5 (5) | – |
*Attack rate = no. case-players/total no. on team, per position. The overall attack rate = 10%.
Figure 3Distribution of locker locations for case-players, methicillin-resistant Staphylococcus aureus (MRSA) nasal carriers, and methicillin-susceptible S. aureus (MSSA) nasal carriers.
Comparison of antimicrobial susceptibility patterns for Staphylococcus aureus isolates from case-players, carriers, and players X and Y*
| Antimicrobial drug | Case-players (2003) | Nasal carriage strains (2003) | Player X | Player Y | ||||
|---|---|---|---|---|---|---|---|---|
| A† | B | C | Wound (2002) | Nasal (2003) | Wound (2002) | Wound (2003) | ||
| Penicillin | R | R | R | R | R | R | R | R |
| Oxacillin | R | R | R | R | R | R | R | R |
| Gentamicin | S | S | NT | S | S | NT | S | S |
| Levofloxacin | I | I | S | R | I | I | I | I |
| Vancomycin | S | S | S | S | S | S | S | S |
| Clindamycin | S | S | S | R | S | S | S | S |
| Tetracycline | S | S | S | S | S | NT | S | S |
| Rifampin | S | S | S | S | S | NT | S | S |
| Trimethoprim-sulfamethoxazole | NT | NT | S | S | NT | S | NT | NT |
*R, resistant; S, susceptible; I, Intermediate; NT, susceptibility was not tested for that particular antimicrobial drug. †Strain A is indistinguishable on pulsed-field gel electrophoresis from a community-associated MRSA strain (USA300).
Comparison of selected potential risk factors and characteristics of case-players and carriers, versus controls
| Risk factor or characteristic | Case-players (%), N = 10* | Controls (%), N = 32 | OR† | 95% CI† | p value† |
|---|---|---|---|---|---|
| Shared bars of soap with teammates | 5 (50) | 2 (6) | 15.0 | 1.69–180 |
|
| Had preexisting cuts or abrasions | 10 (100) | 20 (63) | Undef | 1.08–undef |
|
| Shared towels with teammates | 2 (20) | 1 (3) | 7.8 | 0.34–471 | 0.14 |
| Had recent "boil" | 3 (30) | 2 (6) | 6.4 | 0.58–86 | 0.08 |
| Shared whirlpool tubs with teammates | 8 (80) | 15 (47) | 4.5 | 0.72–49 | 0.07 |
| Used whirlpool tubs | 8 (80) | 16 (50) | 4.0 | 0.63–43 | 0.09 |
| Had recent "insect bites" | 4 (40) | 6 (19) | 2.9 | 0.44–17 | 0.17 |
| Shaved body | 4 (40) | 12 (38) | 1.1 | 0.19–6 | 0.59 |
| Used antimicrobial drugs in prior 3 months | 1 (10) | 6 (19) | 0.5 | 0.01–5 | 0.46 |
| Chafed skin from athletic equipment | 1 (10) | 9 (28) | 0.3 | 0.01–3 | 0.23 |
*Not including 1 case-player who was unavailable for interview. †Fisher exact test. Values in boldface are significant (p <0.05). OR, odds ratio; CI, confidence interval; Undef, undefined or incalculable value. ‡Not including 3 carriers; 1 was unavailable for interview, and 2 had non–strain A genotypes.